$ORGO
Organogenesis Holdings Inc. Stock $orgo

$orgo Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000119312520067198 Filed on March 09, 2020

Income Statement

Concept	2019 Q4	2018 Q4	2017
Revenue	$74.60M	$63.60M	$198.5M
YoY Change	17.3%	19.68%	43.09%
Cost Of Revenue	$20.40M	$17.51M	$61.22M
YoY Change	16.5%	6.63%	27.01%
Gross Profit	$54.30M	$46.09M	$137.3M
YoY Change	17.82%	25.51%	51.65%
Gross Profit Margin	72.79%	72.47%	69.16%
Selling, General & Admin	$52.40M	$47.48M	$133.7M
YoY Change	10.37%	30.48%	43.74%
% of Gross Profit	96.5%	103.01%	97.4%
Research & Development	$3.600M	$3.091M	$9.065M
YoY Change	16.47%	13.02%	44.42%
% of Gross Profit	6.63%	6.71%	6.6%
Depreciation & Amortization	$2.350M	$6.980M	$3.591M
YoY Change	-66.33%		-37.02%
% of Gross Profit	4.33%	15.14%	2.62%
Operating Expenses	$56.00M	$50.57M	$142.8M
YoY Change	10.74%	29.26%	43.78%
Operating Profit	-$1.700M	-$4.480M	-$5.494M
YoY Change	-62.05%	86.51%	-37.39%
Interest Expense	-$2.600M	$2.663M	$8.010M
YoY Change	-197.63%	16.64%	42.35%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$4.773M	-$9.056M
YoY Change	-100.0%	111.29%	52.82%
Pretax Income	-$4.400M	-$9.253M	-$14.55M
YoY Change	-52.45%	98.52%	-1.03%
Income Tax	$0.00	$2.000K	-$7.025M
% Of Pretax Income
Net Earnings	-$4.400M	-$9.255M	-$8.388M
YoY Change	-52.46%	109.01%	-50.62%
Net Earnings / Revenue	-5.9%	-14.55%	-4.23%
Basic Earnings Per Share
Diluted Earnings Per Share	-$44.99K	-$280.6K	-$225.8K
COMMON SHARES
Basic Shares Outstanding	94.74M
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2018 Q4	2017
SHORT-TERM ASSETS
Cash & Short-Term Investments	$60.20M	$21.30M	$100.0K
YoY Change	182.63%	21200.0%	-90.0%
Cash & Equivalents	$60.37M	$21.41M
Short-Term Investments
Other Short-Term Assets	$3.200M	$2.400M	$200.0K
YoY Change	33.33%	1100.0%	-50.0%
Inventory	$22.92M	$13.32M
Prepaid Expenses	$2.953M	$2.328M
Receivables	$39.36M	$34.08M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$125.6M	$71.13M	$300.0K
YoY Change	76.58%	43.01%	-78.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$47.18M	$39.62M
YoY Change	19.08%	-5.91%
Goodwill	$25.54M	$25.54M
YoY Change	0.0%	0.0%
Intangibles	$20.80M	$26.09M
YoY Change	-20.29%	-12.33%
Long-Term Investments
YoY Change
Other Assets	$884.0K	$579.0K	$312.5M
YoY Change	52.68%	-21.22%	0.81%
Total Long-Term Assets	$95.09M	$92.55M	$312.5M
YoY Change	2.74%	-6.5%	0.81%
TOTAL ASSETS
Total Short-Term Assets	$125.6M	$71.13M	$300.0K
Total Long-Term Assets	$95.09M	$92.55M	$312.5M
Total Assets	$220.7M	$163.7M	$312.8M
YoY Change	34.83%	10.06%	0.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.39M	$19.17M
YoY Change	48.12%	0.59%
Accrued Expenses	$23.45M	$20.39M	$3.800M
YoY Change	15.02%	-9.59%	3700.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$2.500M	$100.0K
YoY Change	-100.0%	2400.0%
Long-Term Debt Due	$3.100M	$7.500M
YoY Change	-58.67%
Total Short-Term Liabilities	$59.89M	$56.10M	$3.900M
YoY Change	6.77%	7.93%	680.0%
LONG-TERM LIABILITIES
Long-Term Debt	$49.63M	$49.20M	$0.00
YoY Change	0.88%
Other Long-Term Liabilities	$6.649M	$5.931M	$10.90M
YoY Change	12.11%	288.66%	0.0%
Total Long-Term Liabilities	$56.28M	$5.931M	$10.90M
YoY Change	848.96%	288.66%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$59.89M	$56.10M	$3.900M
Total Long-Term Liabilities	$56.28M	$5.931M	$10.90M
Total Liabilities	$165.1M	$116.6M	$14.80M
YoY Change	41.55%	-25.84%	30.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$171.0M	-$130.2M
YoY Change	31.3%	99.12%
Common Stock	$226.6M	$177.3M
YoY Change	27.81%	253.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	$728.5K
Shareholders Equity	$55.58M	$47.04M	$298.0M
YoY Change
Total Liabilities & Shareholders Equity	$220.7M	$163.7M	$312.8M
YoY Change	34.83%	10.06%	0.45%

Cashflow Statement

Concept	2019 Q4	2018 Q4	2017
OPERATING ACTIVITIES
Net Income	-$4.400M	-$9.255M	-$8.388M
YoY Change	-52.46%	109.01%	-50.62%
Depreciation, Depletion And Amortization	$2.350M	$6.980M	$3.591M
YoY Change	-66.33%		-37.02%
Cash From Operating Activities	-$6.400M	-$60.02M	-$3.493M
YoY Change	-89.34%	59920.0%	-28.29%
INVESTING ACTIVITIES
Capital Expenditures	-$3.450M	-$1.860M	$2.426M
YoY Change	85.48%		78.25%
Acquisitions			$11.79M
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$3.450M	-$1.860M	-$14.87M
YoY Change	85.48%		1093.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$50.34M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	47.07M	81.04M	18.87M
YoY Change	-41.92%	80940.0%	178.44%
NET CHANGE
Cash From Operating Activities	-6.400M	-60.02M	-3.493M
Cash From Investing Activities	-3.450M	-1.860M	-14.87M
Cash From Financing Activities	47.07M	81.04M	18.87M
Net Change In Cash	37.22M	19.16M	500.0K
YoY Change	94.26%		-24.13%
FREE CASH FLOW
Cash From Operating Activities	-$6.400M	-$60.02M	-$3.493M
Capital Expenditures	-$3.450M	-$1.860M	$2.426M
Free Cash Flow	-$2.950M	-$58.16M	-$5.919M
YoY Change	-94.93%		-5.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	127000
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	238000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	884000
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	579000
CY2019Q4	us-gaap	Assets Assets	220687000
CY2018Q4	us-gaap	Assets Assets	163678000
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5000000
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5000000
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	105356948
CY2019	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2019Q4	orgo	Redeemable Common Stock Liability RedeemableCommonStockLiability	0
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Entity Registrant Name EntityRegistrantName	Organogenesis Holdings Inc.
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001661181
CY2019	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Trading Symbol TradingSymbol	ORGO
CY2019	dei	Entity Small Business EntitySmallBusiness	true
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2019	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019	dei	Security12b Title Security12bTitle	Class A Common Stock
CY2019Q4	us-gaap	Cash Cash	60174000
CY2018Q4	us-gaap	Cash Cash	21291000
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	196000
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	114000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2953000
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2328000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	125600000
CY2018Q4	us-gaap	Assets Current AssetsCurrent	71131000
CY2019Q4	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	556000
CY2018Q4	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	477000
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20797000
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26091000
CY2018Q4	orgo	Redeemable Common Stock Liability RedeemableCommonStockLiability	6762000
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0
CY2018Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2545000
CY2019Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3057000
CY2018Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	2236000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	28387000
CY2018Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	15418000
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19165000
CY2019Q4	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	23450000
CY2018Q4	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	20388000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	59894000
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	56096000
CY2019Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	33484000
CY2018Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	26484000
CY2019Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0
CY2019Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1012000
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	130000
CY2019Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	14431000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6649000
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5931000
CY2019Q4	us-gaap	Liabilities Liabilities	165104000
CY2018Q4	us-gaap	Liabilities Liabilities	116637000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	10000
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	9000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	226580000
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	177272000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-171007000
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-130240000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	220687000
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	163678000
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105599434
CY2019	us-gaap	Revenues Revenues	260981000
CY2018	us-gaap	Revenues Revenues	193449000
CY2017	us-gaap	Revenues Revenues	198508000
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	75948000
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	68808000
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	61220000
CY2019	us-gaap	Gross Profit GrossProfit	185033000
CY2018	us-gaap	Gross Profit GrossProfit	124641000
CY2017	us-gaap	Gross Profit GrossProfit	137288000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	199693000
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	161961000
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	133717000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14799000
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10742000
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9065000
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	91261413
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	104870886
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	91261413
CY2019	orgo	Write Off Of Deferred Offering Costs WriteOffOfDeferredOfferingCosts	0
CY2018	orgo	Write Off Of Deferred Offering Costs WriteOffOfDeferredOfferingCosts	3494000
CY2019	us-gaap	Operating Expenses OperatingExpenses	214492000
CY2018	us-gaap	Operating Expenses OperatingExpenses	176197000
CY2017	us-gaap	Operating Expenses OperatingExpenses	142782000
CY2019	orgo	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	-628000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-15979000
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-221000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-919000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-15317000
CY2018	orgo	Stock Issued During Period Value New Issue1 StockIssuedDuringPeriodValueNewIssue1	-91730000
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-119000
CY2018	orgo	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	-2707000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-1075000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	47041000
CY2019	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification	332000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-29459000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-51556000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-5494000
CY2019	us-gaap	Interest Expense InterestExpense	8996000
CY2018	us-gaap	Interest Expense InterestExpense	10789000
CY2017	us-gaap	Interest Expense InterestExpense	8010000
CY2019	orgo	Change In Fair Value Of Warrants ChangeInFairValueOfWarrants	0
CY2018	orgo	Change In Fair Value Of Warrants ChangeInFairValueOfWarrants	469000
CY2017	orgo	Change In Fair Value Of Warrants ChangeInFairValueOfWarrants	1037000
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1862000
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2095000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13000
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	162000
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10845000
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13191000
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9056000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40304000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-64747000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14550000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	150000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	84000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7025000
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-269000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-936000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	55583000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	1075000
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	919000
CY2019	orgo	Non Cash Interest Expense NonCashInterestExpense	243000
CY2018	orgo	Non Cash Interest Expense NonCashInterestExpense	845000
CY2017	orgo	Non Cash Interest Expense NonCashInterestExpense	410000
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-146000
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1209000
CY2017	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	8000
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1166000
CY2019	orgo	Provision For Inventory Reserve ProvisionForInventoryReserve	1297000
CY2018	orgo	Provision For Inventory Reserve ProvisionForInventoryReserve	2473000
CY2017	orgo	Provision For Inventory Reserve ProvisionForInventoryReserve	3170000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	936000
CY2019	us-gaap	Profit Loss ProfitLoss	-40454000
CY2018	us-gaap	Profit Loss ProfitLoss	-64831000
CY2017	us-gaap	Profit Loss ProfitLoss	-7525000
CY2019	us-gaap	Depreciation Depreciation	3388000
CY2018	us-gaap	Depreciation Depreciation	3309000
CY2017	us-gaap	Depreciation Depreciation	3591000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6043000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3669000
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2037000
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	469000
CY2017	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1037000
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1862000
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2095000
CY2019	orgo	Fair Value Adjustment Of Forfeiture Rights FairValueAdjustmentOfForfeitureRights	0
CY2018	orgo	Fair Value Adjustment Of Forfeiture Rights FairValueAdjustmentOfForfeitureRights	589000
CY2017	orgo	Fair Value Adjustment Of Forfeiture Rights FairValueAdjustmentOfForfeitureRights	-212000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4691000
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7110000
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7010000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11063000
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1524000
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1490000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	625000
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1414000
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2680000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4700000
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-60000
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3967000
CY2019	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	2942000
CY2018	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	2354000
CY2017	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	2665000
CY2019	orgo	Increase Decrease In Accrued Interest Of Affiliate Debt IncreaseDecreaseInAccruedInterestOfAffiliateDebt	0
CY2018	orgo	Increase Decrease In Accrued Interest Of Affiliate Debt IncreaseDecreaseInAccruedInterestOfAffiliateDebt	9241000
CY2017	orgo	Increase Decrease In Accrued Interest Of Affiliate Debt IncreaseDecreaseInAccruedInterestOfAffiliateDebt	-3190000
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-930000
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	316000
CY2017	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	159000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33528000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-60635000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3493000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5984000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1857000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2426000
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6234000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1856000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14874000
CY2019	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	7000000
CY2018	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	8866000
CY2017	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	12749000
CY2019	orgo	Proceeds From Affiliates Long Term Debt ProceedsFromAffiliatesLongTermDebt	0
CY2018	orgo	Proceeds From Affiliates Long Term Debt ProceedsFromAffiliatesLongTermDebt	15000000
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	17585000
CY2018	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	10000
CY2017	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6325000
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	269000
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	119000
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	221000
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	924000
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	177000
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	862000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	78727000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81538000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18867000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	38965000
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19047000
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	500000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21405000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2358000
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1858000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60370000
CY2019	us-gaap	Interest Paid InterestPaid	8148000
CY2018	us-gaap	Interest Paid InterestPaid	5423000
CY2017	us-gaap	Interest Paid InterestPaid	6076000
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	49000
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	8000
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	96000
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50340000
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	92000000
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2973000
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	270000
CY2018	orgo	Offering Costs OfferingCosts	270000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-171007000
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	728548
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	37497000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3420000
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34077000
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3225000
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1157000
CY2018	orgo	Allowance For Doubtful Accounts Receivable Write Offs1 AllowanceForDoubtfulAccountsReceivableWriteOffs1	-962000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3420000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3049000
CY2017	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	1159000
CY2018	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	2473000
CY2017	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	3170000
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1206000
CY2019	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	1297000
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1417000
CY2019	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	3096000
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	42408000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3049000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39359000
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	239000
CY2019	orgo	Allowance For Doubtful Accounts Receivable Write Offs1 AllowanceForDoubtfulAccountsReceivableWriteOffs1	-610000
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9178000
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4711000
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	781000
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1759000
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12959000
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6851000
CY2019Q4	us-gaap	Inventory Net InventoryNet	22918000
CY2018Q4	us-gaap	Inventory Net InventoryNet	13321000
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	250000
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1266000
CY2018	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	104000
CY2017	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	81000
CY2019	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	6762000
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	628000
CY2018	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	1923000
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="text-indent: 0.78in; font-family: "times new roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported results of operations during the reporting period. Actual results and outcomes may differ significantly from those estimates and assumptions. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019	orgo	Offering Costs OfferingCosts	3510000
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	79097000
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	62435000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39623000
CY2019Q4	orgo	Operating Lease Amount Of Minimum Rental Payments Increase In Each Year In Ten Year Option To Extend OperatingLeaseAmountOfMinimumRentalPaymentsIncreaseInEachYearInTenYearOptionToExtend	44000
CY2019Q4	orgo	Operating Lease Amount Of Minimum Rental Payments Increase In Each Year In Five Year Option To Extend OperatingLeaseAmountOfMinimumRentalPaymentsIncreaseInEachYearInFiveYearOptionToExtend	33000
CY2019Q4	us-gaap	Security Deposit SecurityDeposit	526000
CY2019	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-263000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	55583000
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47041000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36580000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10489000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	26091000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3267000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3332000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3322000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3358000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-64831000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-8388000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	5676000
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	863000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-40454000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1842000
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9440247
CY2018Q4	us-gaap	Notes Payable NotesPayable	15885000
CY2018Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	762000
CY2018Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2545000
CY2018Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	12578000
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2019Q4	us-gaap	Land Subject To Ground Leases LandSubjectToGroundLeases	43850000
CY2019Q4	us-gaap	Goodwill Goodwill	25539000
CY2018Q4	us-gaap	Goodwill Goodwill	25539000
CY2018Q4	orgo	Accrued Legal Expenses AccruedLegalExpenses	1000000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	111000
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	186000
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7301000
CY2017	orgo	Impairment Of Notes Receivable ImpairmentOfNotesReceivable	113000
CY2017	orgo	Fair Value Adjustment Of Interest Rate Swap FairValueAdjustmentOfInterestRateSwap	6000
CY2019Q4	orgo	Business Combination Contingent Consideration Liability Accrued Interest BusinessCombinationContingentConsiderationLiabilityAccruedInterest	918000
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	15218000
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20388000
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	11790000
CY2017	orgo	Variable Interest Entity Deconsolidation VariableInterestEntityDeconsolidation	666000
CY2017	orgo	Proceeds From Term Loan And Revolver2019 Credit Facility ProceedsFromTermLoanAndRevolver2019CreditFacility	0
CY2019	orgo	Payment Of Recapitalizationcost PaymentOfRecapitalizationcost	0
CY2018	orgo	Payment Of Recapitalizationcost PaymentOfRecapitalizationcost	11206000
CY2017	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	1000000
CY2017	orgo	Payments Of Deferred Acquisition Consideration PaymentsOfDeferredAcquisitionConsideration	2500000
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1883000
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1006000
CY2019	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	0.03
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	5077000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2677000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1874000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	23411000
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	4791000
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	4780000
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	4945000
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	6862000
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	17488000
CY2019Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3057000
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25727963
CY2019Q4	orgo	Shares Reserved For Issuance For Outstanding Options SharesReservedForIssuanceForOutstandingOptions	6503646
CY2018Q4	orgo	Shares Reserved For Issuance For Outstanding Options SharesReservedForIssuanceForOutstandingOptions	6590195
CY2019Q4	orgo	Shares Reserved For Issuance For Future Option Grant SharesReservedForIssuanceForFutureOptionGrant	9008996
CY2018Q4	orgo	Shares Reserved For Issuance For Future Option Grant SharesReservedForIssuanceForFutureOptionGrant	9108996
CY2018Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	17732700
CY2019Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	15512642
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	33431891
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2019	orgo	Deemed Dividends To Warrant Holders DeemedDividendsToWarrantHolders	645000
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Net Minimum Payments1 CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1	24350000
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	37330000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16533000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20797000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	100000
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	248567
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.24
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.39
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1079000
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	963000
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1252000
CY2019	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M2D
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23450000
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	82774000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	65812000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47184000
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5170000
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2290000
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	49634000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7179636
CY2019Q4	orgo	Accrued Legal Expenses AccruedLegalExpenses	542000
CY2019Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	49634000
CY2018Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0224
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0273
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.427
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.420
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	7.08
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	5.99
CY2019Q4	orgo	Fair Value Of Common Share FairValueOfCommonShare	7.08
CY2018Q4	orgo	Fair Value Of Common Share FairValueOfCommonShare	5.82
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M20D
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	9834000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7266185
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.92
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y10M20D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	33909000
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.08
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	34416
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.10
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	152133
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.76
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	715000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7179636
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.98
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y21D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	20799000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6195889
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.64
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M6D
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	19767000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6984130
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.92
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y11M23D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	20603000
CY2019	orgo	Deferred Interest Expense DeferredInterestExpense	1446000
CY2018	orgo	Deferred Interest Expense DeferredInterestExpense	249000
CY2017	orgo	Deferred Interest Expense DeferredInterestExpense	233000
CY2019	orgo	Non Cash Rent Expense Income NonCashRentExpenseIncome	882000
CY2018	orgo	Non Cash Rent Expense Income NonCashRentExpenseIncome	56000
CY2017	orgo	Non Cash Rent Expense Income NonCashRentExpenseIncome	70000
CY2019	orgo	Proceeds From Term Loan And Revolver2019 Credit Facility ProceedsFromTermLoanAndRevolver2019CreditFacility	50000000
CY2017	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	16000000
CY2018	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	22680000
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17640000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5810000
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	366000
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	6231000
CY2018	us-gaap	Operating Lease Expense OperatingLeaseExpense	4628000
CY2017	us-gaap	Operating Lease Expense OperatingLeaseExpense	4205000
CY2019Q2	dei	Entity Public Float EntityPublicFloat	48400000
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	1052000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	5661000
CY2017	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	423000
CY2018	orgo	Net Income Loss Attribute To Parent NetIncomeLossAttributeToParent	-64831000
CY2017	orgo	Net Income Loss Attribute To Parent NetIncomeLossAttributeToParent	-8811000
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	69318456
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	63876767
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.94
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2017	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	10270000
CY2017	us-gaap	Stockholders Equity Other StockholdersEquityOther	-9336000
CY2017	orgo	Adjustments To Additional Paid In Capital Extinguishment Of Debt AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDebt	4577000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	959000
CY2017	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	1000000
CY2017	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	423000
CY2018	orgo	Adjustments To Additional Paid In Capital Recapitalization Cost AdjustmentsToAdditionalPaidInCapitalRecapitalizationCost	-11206000
CY2018	orgo	Stock Issued During Period Value Extinguishment Of Debt StockIssuedDuringPeriodValueExtinguishmentOfDebt	-42764000
CY2019	orgo	Summaryofestimatedusefullivesofpropertyplantandequipmenttabletextblock Summaryofestimatedusefullivesofpropertyplantandequipmenttabletextblock	Property and equipment estimated useful lives are as follows: <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="padding: 0px; width: 48%;"></td><td style="padding: 0px; width: 4%;;vertical-align:bottom;"></td><td style="padding: 0px;;width:69%;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;">Leasehold improvements  </td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Lesser of the life of the lease or the<br/>economic life of the asset</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgba(255, 255, 255, 0); width: 48%;;vertical-align:top;">Furniture and computers</td><td style="background-color: rgba(255, 255, 255, 0); width: 4%;;vertical-align:bottom;">  </td><td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:top;">3<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-size: 10pt; line-height: 115%; font-family: "times new roman", serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">- </div></div>5 years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;">Equipment</td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">5<div style="font-size: 10pt; line-height: 115%; font-family: "times new roman", serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> - </div></div>10 years</td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	36511000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	34707000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	4075000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	3208000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	21000
CY2019Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	11858000
CY2018Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	12219000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	633000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	29000
CY2019Q4	us-gaap	Fresh Start Adjustment Increase Decrease Assets FreshStartAdjustmentIncreaseDecreaseAssets	1280000
CY2018Q4	us-gaap	Fresh Start Adjustment Increase Decrease Assets FreshStartAdjustmentIncreaseDecreaseAssets	-2765000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	54378000
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	47424000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54251000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	47186000
CY2018	us-gaap	Accretion Expense AccretionExpense	0
CY2017	us-gaap	Accretion Expense AccretionExpense	423000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	47186000
CY2019Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3192000
CY2018Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3722000
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3801000
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	269000
CY2018	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	209000
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7065000
CY2019Q4	orgo	Operating Loss Carry Forwards Tax Credit Research OperatingLossCarryForwardsTaxCreditResearch	919000
CY2018Q4	orgo	Prepaid Subscription PrepaidSubscription	594000
CY2018Q4	us-gaap	Supplies Supplies	116000
CY2018Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	392000
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	223000
CY2018Q4	orgo	Prepaid Deposits PrepaidDeposits	764000
CY2018Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	239000
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2953000
CY2018Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2328000
CY2018	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	64000
CY2017	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	111000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	270000
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
CY2019	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3510000
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	35282700
CY2019	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3286000
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3486000
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3663000
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	133000
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	157000
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	231000
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	801000
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	357000
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	408000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2618000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	106000
CY2018	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance State Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceStatePercent	-0.039
CY2019Q4	orgo	Prepaid Subscription PrepaidSubscription	1041000
CY2019Q4	us-gaap	Supplies Supplies	291000
CY2019Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	925000
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	472000
CY2019Q4	orgo	Prepaid Deposits PrepaidDeposits	87000
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	137000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1224000
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	6898000
CY2019	orgo	Net Income Loss Attribute To Parent NetIncomeLossAttributeToParent	-41099000
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	92840401
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-105000
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-212000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	116000
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	101000
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	214000
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	28000
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	9000
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	62000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	39000
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-102000
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	276000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	105000
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	212000
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-6401000
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-900000
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	6000
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-26000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	150000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	84000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7025000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	26000
CY2019Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50340000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2017	orgo	Effective Income Tax Rate Reconciliation Tax Reform Act EffectiveIncomeTaxRateReconciliationTaxReformAct	-1.344
CY2019	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederalPercent	-0.176
CY2018	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederalPercent	-0.184
CY2017	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederalPercent	1.475
CY2019	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance State Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceStatePercent	-0.039
CY2017	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance State Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceStatePercent	0.030
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.035
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.035
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.023
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.014
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.023
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.068
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.022
CY2018	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	-0.001
CY2017	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	-0.005
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.019
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.004
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.483
CY2019	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	-0.001
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54251000
CY2019	orgo	Description Of Recognized Tax Benefits Upon Ultimate Settlement DescriptionOfRecognizedTaxBenefitsUponUltimateSettlement	The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	46831000
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2017	orgo	Accretion Of Redeemable Common Shares AccretionOfRedeemableCommonShares	-423000
CY2019	orgo	Noncashdeemeddividend To Warrant Holders NoncashdeemeddividendToWarrantHolders	-645000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-41099000
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-64831000
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8811000
CY2019Q4	orgo	Operating Loss Carryforward Indefinately OperatingLossCarryforwardIndefinately	59376000
CY2017	orgo	Repayment Of Mortgage Notes Payables Real Estate Entities Net RepaymentOfMortgageNotesPayablesRealEstateEntitiesNet	1335000
CY2019	orgo	Warrantliabilitypolicytextblockpolicytextblock Warrantliabilitypolicytextblockpolicytextblock	<div style="font-family: "times new roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Warrant Liability </div></div></div></div><div style="text-indent: 0.78in; font-family: "times new roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with the issuance of the 2016 Loans, the Company issued to the loan holders warrants to purchase shares of Class A common stock. The Company classifie<div style="letter-spacing: 0px; top: 0px;;display:inline;">d</div> the warrants as a liability on its consolidated </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">balance sheet because each warrant provided for down-round protection which would cause the exercise price of the warrants to be adjusted if future equity issuances were below the current exercise price of the warrants. </div></div> <div style="color: rgb(0, 0, 0); font-family: "times new roman"; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0px; orphans: 2; text-align: start; text-indent: 4%; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;">The price of the warrant was also subject to adjustment any time the price of another equity-linked instrument changed. The warrant liability was initially recorded at fair value upon issuance and was subsequently remeasured to fair value at each reporting date until the warrants were net exercised in December 2018 in connection with the Avista Merger. Changes in the fair value of the warrant liability were recognized as a component of other income (expense), net in the consolidated statements of operations. The Company had no warrant liability as of December 31, 2019 and 2018.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Reclassification of Prior Period Balances </div></div></div></div><div style="text-indent: 0.78in; font-family: "times new roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; top: 0px;;display:inline;">Reclassifications have been made to prior period amounts to conform to the current-year presentation of the reporting of deferred interest and principal on outstanding capital lease obligations and </div></div><div style="background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="color: rgb(0, 0, 0); font-family: "times new roman"; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0px; orphans: 2; text-align: start; text-indent: 4%; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"><div style="background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; top: 0px;;display:inline;">unpaid operating and common area maintenance costs as long-term liabilities on the consolidated balance sheets. The deferred interest and unpaid operating and common area maintenance costs were previously reported as accrued expenses on the consolidated balance sheets and the deferred principal on the capital lease obligations were recorded as part of the current portion of capital lease obligations on the consolidated balance sheet. These reclassifications have no effect on the reported net loss or equity for the years ended December 31, 2018 and 2017.</div></div><div style="background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-indent: 0.78in; font-family: "times new roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; top: 0px;;display:inline;">Reclassification has been made to prior period amounts reported in the cash flows from operating activities section of the consolidated cash flow statements to conform to the current year presentation. The provision recorded for inventory reserve has been reduced by amounts not related to excess and obsolete inventory and change in inventory has been increased by a corresponding amount. The reclassification has no effect on the reported balance sheet as of December 31, 2018 or net loss or equity </div></div></div><div style="background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="color: rgb(0, 0, 0); font-family: "times new roman"; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0px; orphans: 2; text-align: start; text-indent: 4%; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"><div style="background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; top: 0px;;display:inline;">or total operating, investing or financing cash flows for the years ended December 31, 2018 and 2017.</div></div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019	orgo	Recentlyadoptedaccountingpronouncementspolicytextblock Recentlyadoptedaccountingpronouncementspolicytextblock	<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Recently Adopted Accounting Pronouncements </div></div></div></div><div style="text-indent: 0.78in; font-family: "times new roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In May 2014, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2014-09,</div> <div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Revenue from Contracts with Customers (Topic 606)</div> (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2014-09”).</div> This ASU amends the guidance for revenue recognition, creating the new ASC Topic 606 (“ASC 606”). The core principle of ASC 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: identify the contract(s) with a customer; identify the performance obligations in the contract; determine the transaction price; allocate the transaction price to the performance obligations in the contract; and recognize revenue when (or as) the entity satisfies a performance obligation. ASC 606 supersedes the revenue recognition requirements in ASC 605, Revenue Recognition, most industry-specific guidance throughout the industry topics of the accounting standards codification, and some cost guidance related to construction-type and production-type contracts. This ASC is effective for private entities for annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. The Company is a public entity but took advantage of the relief provided for emerging growth companies and adopted this standard on January 1, 2019. The adoption of ASC 606 did not have a material impact on the Company’s consolidated financial position, results of operations, equity or cash flows as of the adoption date or for the year ended December 31, 2019. <div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"> </div>In September 2018, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2018-07,</div> <div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</div>. This ASU expands the scope of <div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Topic 718, Compensation—Stock Compensation</div> to include share-based payments issued to nonemployees for goods or services. Under the new guidance, the existing employee guidance will apply to nonemployee share-based transactions (as long as the transaction is not effectively a form of financing), with the exception of specific guidance related to the attribution of compensation cost. The cost of nonemployee awards will continue to be recorded as if the grantor had paid cash for the goods or services. The accounting standards update is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. The Company adopted this standard, beginning with its financial reporting for the quarter ended June 30, 2019 due to the option activity to nonemployees in this quarter. The adoption of this standard did not have any material effect on the Company’s consolidated financial statements or any component of stockholders’ equity.</div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	78000
CY2019	orgo	Capital Lease Month Of Expiry CapitalLeaseMonthOfExpiry	2022-12
CY2018	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	42764000
CY2018	orgo	Fair Value Of Shares Issued In Connection With Settlement Of Investor Warrants FairValueOfSharesIssuedInConnectionWithSettlementOfInvestorWarrants	2707000
CY2018	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	1000
CY2018	orgo	Exercise Of Put Option Redeemable Common Stock ExerciseOfPutOptionRedeemableCommonStock	6762000
CY2019	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	537000
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4014000
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	172000
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	764000
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	500000
CY2019	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1099000
CY2017	orgo	Notes Payable Converted Warrants Issued NotesPayableConvertedWarrantsIssued	959000
CY2017	orgo	Non Cash Extinguishment Of Subordinated Notes Of Affiliates NonCashExtinguishmentOfSubordinatedNotesOfAffiliates	4577000
CY2017	orgo	Non Cash Accretion Of Redeemable Common Stock NonCashAccretionOfRedeemableCommonStock	423000
CY2017	orgo	Shares Issued Issued In Connection With Acquisition SharesIssuedIssuedInConnectionWithAcquisition	16609000
CY2017	orgo	Non Cash Deconsolidation Of Variable Interest Entities NonCashDeconsolidationOfVariableInterestEntities	9052000
CY2017	orgo	Issue Of Deferred Acquisition Consideration IssueOfDeferredAcquisitionConsideration	7500000
CY2017	orgo	Issue Of Contingent Consideration IssueOfContingentConsideration	377000
CY2018	orgo	Write Off Of Deferred Offering Cost WriteOffOfDeferredOfferingCost	3494000
CY2019Q4	orgo	Deferred Tax Asset Reclassified Alternative Minimum Tax Percentage DeferredTaxAssetReclassifiedAlternativeMinimumTaxPercentage	0.50
CY2019	orgo	Emerginggrowthcompanypolicytextblock Emerginggrowthcompanypolicytextblock	<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Emerging Growth Company </div></div></div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;">Section </div><div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">102</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;">(b)</div><div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">(1)</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;"> of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of </div><div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">1934</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;">, as amended (the ”Exchange Act”) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. For example, the Company will adopt ASU </div><div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">2016-02</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;">,</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt;;font-style:italic;display:inline;;font-style:italic;display:inline;"> Leases (Topic 842)</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;"> on January </div><div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">1</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;">, </div><div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">2021</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;"> and ASU </div><div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">2016-13</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt;;font-style:italic;display:inline;;font-style:italic;display:inline;">, Financial Instruments—Credit Losses (Topic 326) on </div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;">January </div><div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">1</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;">, </div><div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">2023</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;">. As a result, the Company’s financial statements may not be comparable to other public companies. The Company may take advantage of these exemptions up until the last day of the fiscal year following October </div><div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">14</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;">, </div><div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">2021</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;">, the fifth anniversary of its IPO, or such earlier time that it is no longer an emerging growth company. It would cease to be an emerging growth company if the Company has more than $</div>1.07<div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;"> billion in annual revenue, the Company has more than $</div>700<div style="font-size: 10pt; text-indent: 0.78in; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px;;display:inline;">.0</div><div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;"> million in market value of its stock held by non-affiliates or the Company issues more than $</div>1.0<div style="font-size: 10pt; background-color: rgba(255, 255, 255, 0); letter-spacing: 0px; font-family: "times new roman", serif; text-indent: 24.5pt; top: 0px;;display:inline;"> billion of non-convertible debt securities over a three-year period.</div><div style="font-size: 10pt; text-indent: 0.78in; letter-spacing: 0px; background-color: rgba(255, 255, 255, 0); top: 0px;;display:inline;"> </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q4	orgo	Working Capital WorkingCapital	65706000

Files In Submission

Name	View Source	Status
0001193125-20-067198-index-headers.html	Edgar Link	pending
0001193125-20-067198-index.html	Edgar Link	pending
0001193125-20-067198.txt	Edgar Link	pending
0001193125-20-067198-xbrl.zip	Edgar Link	pending
d844864d10k.htm	Edgar Link	pending
d844864dex1041.htm	Edgar Link	pending
d844864dex1042.htm	Edgar Link	pending
d844864dex211.htm	Edgar Link	pending
d844864dex231.htm	Edgar Link	pending
d844864dex311.htm	Edgar Link	pending
d844864dex312.htm	Edgar Link	pending
d844864dex321.htm	Edgar Link	pending
d844864dex41.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g844864g0307031502083.jpg	Edgar Link	pending
g844864g0307031502302.jpg	Edgar Link	pending
g844864g0307031502426.jpg	Edgar Link	pending
g844864g0307031502567.jpg	Edgar Link	pending
g844864g0307031502707.jpg	Edgar Link	pending
g844864g0307031502848.jpg	Edgar Link	pending
g844864g0307031502988.jpg	Edgar Link	pending
g844864g0307031503144.jpg	Edgar Link	pending
g844864g0307031503300.jpg	Edgar Link	pending
g844864g0307031503472.jpg	Edgar Link	pending
g844864g0307031503628.jpg	Edgar Link	pending
g844864g0307031503799.jpg	Edgar Link	pending
g844864g0307031504002.jpg	Edgar Link	pending
g844864g0307031504330.jpg	Edgar Link	pending
g844864g0307031504532.jpg	Edgar Link	pending
g844864g0307031504720.jpg	Edgar Link	pending
g844864g0307031504922.jpg	Edgar Link	pending
g844864g0307031505125.jpg	Edgar Link	pending
g844864g0307031505328.jpg	Edgar Link	pending
g844864g0307031505531.jpg	Edgar Link	pending
g844864g0307031505765.jpg	Edgar Link	pending
g844864g0307031505983.jpg	Edgar Link	pending
orgo-20191231.xml	Edgar Link	completed
orgo-20191231.xsd	Edgar Link	pending
orgo-20191231_cal.xml	Edgar Link	unprocessable
orgo-20191231_def.xml	Edgar Link	unprocessable
orgo-20191231_lab.xml	Edgar Link	unprocessable
orgo-20191231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGO
Organogenesis Holdings Inc. Stock $orgo

2019 Q4 Form 10-K Financial Statement

#000119312520067198 Filed on March 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGO Organogenesis Holdings Inc. Stock $orgo

2019 Q4 Form 10-K Financial Statement

#000119312520067198 Filed on March 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGO
Organogenesis Holdings Inc. Stock $orgo